Compound ID | 314

CP-5068

Class: Beta-lactam (carbapenem)

Spectrum of activity: Gram-negative
Details of activity: Cell wall inhibitors; effective against MRSA, PRSP and severe pneumococcal infections
Propensity to select resistant mutants: Yes
Institute where first reported: Meiji Seika Kaisha (Meiji Seika Pharma., Japan)
Year first mentioned: 2000
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 436.51
Iso. SMILES: C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1C3=CN4C=[N+](C(=C4S3)SC)CC(=O)N)C(=O)[O-])[C@@H](C)O
InChI Key: VSVRJBUXAZABAX-XDPNNTCOSA-N
Can. SMILES: C[C@H]1C(=C(C(=O)[O-])N2[C@H]1[C@@H]([C@@H](C)O)C2=O)C3=CN4C=[N+](CC(=O)N)C(=C4S3)SC
InChI: InChI=1S/C18H20N4O5S2/c1-7-11(14(18(26)27)22-13(7)12(8(2)23)15(22)25)9-4-20-6-21(5-10(19)24)16(28-3)17(20)29-9/h4,6-8,12-13,23H,5H2,1-3H3,(H2-,19,24,26,27)/t7-,8+,12+,13+/m0/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/9803074
Citation:

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.